GSK Investigational Site

Miramichi, New Brunswick E1V 6X3

0 studies enrolling now · 6 studies all time

What they study most

Anxiety Disorders, Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), Neoplasms, Prostate, Schizophrenia, Social Anxiety Disorder, Social Phobia

Studies at this site

• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder — Stopped early
• Treatment Of Patients With Social Anxiety Disorder — Completed
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder — Completed
• Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Study Of GW679769 In Major Depressive Disorder — Completed